AdaptHealth Corp. reported a net loss of $145.3 million for the quarter ended June 30, 2026, driven by a $144.2 million pre-tax goodwill impairment charge. Net revenue increased 12.7% to $740.3 million, while Adjusted EBITDA declined 3.2% to $132.0 million. The company revised its full-year fiscal 2026 financial outlook downward due to margin pressures from a West Coast capitated contract transition and manufacturer price increases. Subsequent to the quarter-end, AdaptHealth entered into a definitive agreement to sell its Diabetes Health business for $235.0 million in cash, which will be reported as discontinued operations. Additionally, the company redeemed its 6.125% Senior Notes due 2028 using proceeds from a $325 million delayed draw term loan and completed a workforce restructuring generating $19 million in annualized savings. AdaptHealth operates in the healthcare industry, providing patient-centered home medical equipment, supplies, and related services.
